Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS)
CNY 3.56
(2.3%)
CNY 3.56
(2.3%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 19.41 Billion CNY | -10.15% |
| 2022 | 21.61 Billion CNY | 19.82% |
| 2021 | 18.03 Billion CNY | 56.62% |
| 2020 | 11.51 Billion CNY | 98.98% |
| 2019 | 5.78 Billion CNY | 0.45% |
| 2018 | 5.76 Billion CNY | 17.53% |
| 2017 | 4.9 Billion CNY | -1.52% |
| 2016 | 4.97 Billion CNY | 24.07% |
| 2015 | 4.01 Billion CNY | -4.1% |
| 2014 | 4.18 Billion CNY | 41.66% |
| 2013 | 2.95 Billion CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2.4 Billion CNY | -43.77% |
| 2024 Q3 | 2.26 Billion CNY | 1.25% |
| 2024 Q2 | 2.24 Billion CNY | -6.66% |
| 2023 Q4 | 4.27 Billion CNY | -16.43% |
| 2023 FY | 19.41 Billion CNY | -10.15% |
| 2023 Q1 | 4.81 Billion CNY | -22.42% |
| 2023 Q2 | 5.24 Billion CNY | 8.94% |
| 2023 Q3 | 5.11 Billion CNY | -2.64% |
| 2022 Q1 | 4.15 Billion CNY | -11.89% |
| 2022 FY | 21.61 Billion CNY | 19.82% |
| 2022 Q3 | 6.58 Billion CNY | 41.24% |
| 2022 Q4 | 6.21 Billion CNY | -5.69% |
| 2022 Q2 | 4.66 Billion CNY | 12.2% |
| 2021 Q3 | 5.1 Billion CNY | 17.95% |
| 2021 Q4 | 4.71 Billion CNY | -7.57% |
| 2021 Q1 | 3.89 Billion CNY | -6.89% |
| 2021 Q2 | 4.32 Billion CNY | 11.09% |
| 2021 FY | 18.03 Billion CNY | 56.62% |
| 2020 Q4 | 4.18 Billion CNY | 28.81% |
| 2020 Q2 | 2.33 Billion CNY | 33.85% |
| 2020 FY | 11.51 Billion CNY | 98.98% |
| 2020 Q1 | 1.74 Billion CNY | 14.61% |
| 2020 Q3 | 3.24 Billion CNY | 38.75% |
| 2019 FY | 5.78 Billion CNY | 0.45% |
| 2019 Q4 | 1.52 Billion CNY | -1.7% |
| 2019 Q3 | 1.55 Billion CNY | 13.13% |
| 2019 Q2 | 1.37 Billion CNY | 2.39% |
| 2019 Q1 | 1.33 Billion CNY | -12.53% |
| 2018 Q2 | 1.38 Billion CNY | 1.87% |
| 2018 Q4 | 1.53 Billion CNY | 2.56% |
| 2018 Q3 | 1.49 Billion CNY | 8.1% |
| 2018 FY | 5.76 Billion CNY | 17.53% |
| 2018 Q1 | 1.35 Billion CNY | -6.13% |
| 2017 FY | 4.9 Billion CNY | -1.52% |
| 2017 Q1 | 1.12 Billion CNY | -25.3% |
| 2017 Q2 | 1.14 Billion CNY | 1.84% |
| 2017 Q3 | 1.19 Billion CNY | 4.54% |
| 2017 Q4 | 1.44 Billion CNY | 20.96% |
| 2016 Q4 | 1.5 Billion CNY | 13.54% |
| 2016 FY | 4.97 Billion CNY | 24.07% |
| 2016 Q3 | 1.32 Billion CNY | 0.0% |
| 2015 FY | 4.01 Billion CNY | -4.1% |
| 2014 FY | 4.18 Billion CNY | 41.66% |
| 2013 FY | 2.95 Billion CNY | 0.0% |